Search Results - "Meuer, Katrin"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy by Frank, Tobias, Schlachetzki, Johannes C M, Göricke, Bettina, Meuer, Katrin, Rohde, Gundula, Dietz, Gunnar P H, Bähr, Mathias, Schneider, Armin, Weishaupt, Jochen H

    Published in BMC neuroscience (14-05-2009)
    “…The hematopoietic Granulocyte-Colony Stimulating Factor (G-CSF) plays a crucial role in controlling the number of neutrophil progenitor cells. Its function is…”
    Get full text
    Journal Article
  3. 3

    Application of a blood–brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease by Dietz, Gunnar P.H., Valbuena, Paola C., Dietz, Birgit, Meuer, Katrin, Müller, Patrick, Weishaupt, Jochen H., Bähr, Mathias

    Published in Brain research (12-04-2006)
    “…Glial-cell-line-derived neurotrophic factor (GDNF) promotes mesencephalic dopaminergic neuronal survival in several in vitro and in vivo models. As the demise…”
    Get full text
    Journal Article
  4. 4

    A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease by Liebetanz, David, Baier, Paul Christian, Paulus, Walter, Meuer, Katrin, Bähr, Mathias, Weishaupt, Jochen H.

    Published in Experimental neurology (01-05-2007)
    “…The subchronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP) paradigm is one of the most widely used in vivo models of Parkinson's disease (PD). However,…”
    Get full text
    Journal Article
  5. 5

    Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra by Dietz, Gunnar P.H, Stockhausen (née Peters), Kerstin V, Dietz, Birgit, Falkenburger, Björn H, Valbuena, Paola, Opazo, Felipe, Lingor, Paul, Meuer, Katrin, Weishaupt, Jochen H, Schulz, Jörg B, Bähr, Mathias

    Published in Journal of neurochemistry (01-02-2008)
    “…The anti-apoptotic Bcl-xL is a promising agent to prevent neurodegeneration in Parkinson's disease, which is characterized by a demise of dopaminergic neurons…”
    Get full text
    Journal Article
  6. 6

    Membrane‐permeable Bcl‐x L prevents MPTP‐induced dopaminergic neuronal loss in the substantia nigra by Dietz, Gunnar P. H., Stockhausen (née Peters), Kerstin V., Dietz, Birgit, Falkenburger, Björn H., Valbuena, Paola, Opazo, Felipe, Lingor, Paul, Meuer, Katrin, Weishaupt, Jochen H., Schulz, Jörg B., Bähr, Mathias

    Published in Journal of neurochemistry (01-02-2008)
    “…The anti‐apoptotic Bcl‐x L is a promising agent to prevent neurodegeneration in Parkinson’s disease, which is characterized by a demise of dopaminergic…”
    Get full text
    Journal Article